Diagnostics News and Research

RSS

University Of Virginia Gets $14.4M Grant To Fight Hypertrophic Cardiomyopathy

...

28 Aug 2013

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

Cepheid today announced the U.S. Food & Drug Administration has categorized Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments.

28 Aug 2013

Institut Curie's Emmanuel Barillot receives Agilent Thought Leader Award

Agilent Technologies Inc. today announced that Dr. Emmanuel Barillot, director of Bioinformatics and Systems IT at the Institut Curie in Paris, has received an Agilent Thought Leader Award in recognition of his pioneering development of user-friendly, Web-based bioinformatics tools for systems toxicology.

28 Aug 2013

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

A recently reported blood test for the early detection of organ transplant injury could enable more timely therapeutic intervention in transplant patients and thus help to avoid longer term damage. As described by scientists at the University Medical Center G-ttingen and Chronix Biomedical, a molecular diagnostics company, the new method uses Bio-Rad Laboratories' Droplet Digital PCR (ddPCR-) technology to overcome the obstacles of earlier tests, which were both time-consuming and costly.

28 Aug 2013

Thermo Scientific releases portable picoSpin 80 NMR spectrometer for benchtop operation

Academic and industrial laboratories can now easily collect routine high-resolution nuclear magnetic resonance (NMR) data on molecules in solution using the Thermo Scientific picoSpin 80, a portable, competitively-priced NMR spectrometer built for benchtop operation. The instrument's magnet, rated at 2 Tesla, is designed to provide superior resolution of chemical and structural characteristics not available using lower magnetic field strengths.

28 Aug 2013

Researchers develop low-cost technology to detect cancer

While many college football fans are focused on this week's marquee matchup between the Georgia Bulldogs and the Clemson Tigers, researchers from the two institutions are working together off the playing field to develop low-cost technology that can detect cancer.

28 Aug 2013

Haplogen, Cemm Offer Huge Collection Of Mutant Cell Lines

...

27 Aug 2013

Novel Parkinson’S Target Uncovered

Researchers from Johns Hopkins and the National Cancer Institute (NCI) highlighted a novel mechanism underlying Parkinson's disease while simultaneously putting to rest a previously held theory regarding progression of the disorder. They also identified a compound that alleviates the disease's symptoms in mice.

27 Aug 2013

Life Technologies announces end-to-end sequencing solution for whole human exome CNV analysis

Life Technologies Corporation today announced the first end-to-end sequencing solution for exon-level copy number variation analysis, which combines the Ion Reporter CNV data analysis workflow, the Ion AmpliSeq Exome Kit and the Ion Proton® System.

27 Aug 2013

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Companion diagnostics is critical in helping to pave the way for personalized medicine, in which the treatment is adapted and precisely tailored to the patient.

From Siemens Healthineers 27 Aug 2013

Two Genomic Pathways Tagged For Roles In Schizophrenia

...

26 Aug 2013

BARDA Awards Novan $7.8M To Develop Thermal Burns Treatment

...

26 Aug 2013

CA-125: Screening tool to detect ovarian cancer in early stages

Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas MD Anderson Cancer Center.

26 Aug 2013

Scientists Shed New Light On Malignant Pancreatic Cancer

...

23 Aug 2013

Athera Transfers Annexin A5 Project To Medirista

...

23 Aug 2013

AVERT System receives FDA clearance for controlled infusion of radiopaque contrast media in angiographic procedures

Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.

23 Aug 2013

INTEGRA Biosciences enters into UK market with local sales team

INTEGRA Biosciences has announced, as of August 1st 2013, a direct sales / support team in the UK to further improve support of its local customer base.

From INTEGRA Biosciences 23 Aug 2013

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Mentors International and Co-Diagnostics HBDC signed an agreement to lower real-time PCR test prices in the developing world, starting with tuberculosis. Under the agreement, Co-Diagnostics HBDC will provide low-cost testing reagents and Mentors International will leverage its international connections to set up low-cost testing facilities.

23 Aug 2013

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.

23 Aug 2013

Researchers receive $1M grant to research in biological components with solid-state electronics

An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.

23 Aug 2013

Diagnostics News and Research

University Of Virginia Gets $14.4M Grant To Fight Hypertrophic Cardiomyopathy

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

Institut Curie's Emmanuel Barillot receives Agilent Thought Leader Award

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

Thermo Scientific releases portable picoSpin 80 NMR spectrometer for benchtop operation

Researchers develop low-cost technology to detect cancer

Haplogen, Cemm Offer Huge Collection Of Mutant Cell Lines

Novel Parkinson’S Target Uncovered

Life Technologies announces end-to-end sequencing solution for whole human exome CNV analysis

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Two Genomic Pathways Tagged For Roles In Schizophrenia

BARDA Awards Novan $7.8M To Develop Thermal Burns Treatment

CA-125: Screening tool to detect ovarian cancer in early stages

Scientists Shed New Light On Malignant Pancreatic Cancer

Athera Transfers Annexin A5 Project To Medirista

AVERT System receives FDA clearance for controlled infusion of radiopaque contrast media in angiographic procedures

INTEGRA Biosciences enters into UK market with local sales team

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Researchers receive $1M grant to research in biological components with solid-state electronics

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News